| 1 | Cancer | 2.13% | |
| 2 | May | 2.13% | |
| 3 | ASCO | 2.13% | |
| 4 | Bladder | 1.06% | |
| 5 | Dodo | 1.06% | |
| 6 | Presentaran | 1.06% | |
| 7 | Retention | 1.06% | |
| 8 | Dog | 1.06% | |
| 9 | Risk | 1.06% | |
| 10 | Vaccine | 1.06% | |
| 11 | CDC | 1.06% | |
| 12 | Study | 1.06% | |
| 13 | Subgroup | 1.06% | |
| 14 | Alternativa | 1.06% | |
| 15 | Infant | 1.06% | |
| 16 | New | 1.06% | |
| 17 | Preventiva | 1.06% | |
| 18 | Patients | 1.06% | |
| 19 | Invasive | 1.06% | |
| 20 | Exploratory | 1.06% | |
| 21 | H.I.V. | 1.06% | |
| 22 | Low-Grade | 1.06% | |
| 23 | Administration | 1.06% | |
| 24 | Homologous | 1.06% | |
| 25 | Science | 1.06% | |
| 26 | Associations | 1.06% | |
| 27 | Cervical | 1.06% | |
| 28 | Medicina | 1.06% | |
| 29 | Years | 1.06% | |
| 30 | Intelligence | 1.06% | |
| 31 | Intermediate-Risk | 1.06% | |
| 32 | ENVISION | 1.06% | |
| 33 | Antipsychotic | 1.06% | |
| 34 | Alone | 1.06% | |
| 35 | Improve | 1.06% | |
| 36 | Ends | 1.06% | |
| 37 | Duration | 1.06% | |
| 38 | Program | 1.06% | |
| 39 | Alterations | 1.06% | |
| 40 | Treatment | 1.06% | |
| 41 | UGN-102 | 1.06% | |
| 42 | Recombination | 1.06% | |
| 43 | 18-Month | 1.06% | |
| 44 | Your | 1.06% | |
| 45 | Lower | 1.06% | |
| 46 | Report | 1.06% | |
| 47 | Following | 1.06% | |
| 48 | Analyses | 1.06% | |
| 49 | Efficacy | 1.06% | |
| 50 | Help | 1.06% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||